Tarsus Pharmaceuticals, Inc. (TARS): Weighted Average Diluted Shares
41.78M
Year ended 2025-12-31
+19.3%
3-year compound annual growth
+46.4%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 41.78M | +11.1% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | 37.60M | +28.0% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | 29.38M | +19.3% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | 24.62M | +19.8% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | 20.55M | +231.1% | 2023-03-17, From 2021-01-01 |
| 2020-12-31 | 6.21M | n/a | 2022-03-14, From 2020-01-01 |